Q3 2021

Filed Nov 9, 2021 · 10-Q · 40 days after period end · 0001062822-21-000063

Q3 2021 · 10-Q

Revenue

$0.00

— vs Q3 2020

Net Income

-$23.12M

N/M vs Q3 2020

EPS Diluted

-$0.16

N/M vs Q3 2020

Operating Income-$22,962,000N/M

Operating Cash Flow

Same quarter

Metric	Q3 2021	Q3 2020	Q3 2019	Q3 2016
Revenue	$0.00	$0.00	$285.91M	$27.67M
Net Income	-$23.12M	$82.60M	$226.09M	-$30.72M
EPS Diluted	-$0.16	$0.71	$1.95	-$0.28

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR